Semaglutide vs AOD-9604: Head-to-Head Comparison
Semaglutide is an FDA-approved blockbuster for obesity with robust clinical evidence, while AOD-9604 is a fragment of human growth hormone (hGH 177-191) with limited and disappointing clinical trial results. AOD-9604 failed to outperform placebo in Phase IIb/III obesity trials.
Approved options in this comparison
Semaglutide is currently modeled on this site as an approved treatment path for: Type 2 diabetes mellitus; chronic weight management in adults with obesity or overweight with comorbidities. Brand names in the current dataset: Ozempic, Wegovy, Rybelsus.
Want to discuss Semaglutide with a provider?
Semaglutide is currently modeled on this site as an approved treatment path. Use the provider matcher to narrow fit by state, insurance, budget, and urgency.
Join provider rolloutSemaglutide Next Steps
FR selected - using US-first conversion assetsUse the reviewed cost hub before you commit to a provider path or a self-pay workflow.
Open cost guide ->Validate reminder, refill, and symptom-tracking demand before the full PWA launches.
Open tracker landing ->Side-by-Side Comparison
| Dimension | Semaglutide | AOD-9604 |
|---|---|---|
| Evidence Level | Phase III trials, FDA-approved, extensive real-world data | Failed Phase IIb/III trials for obesity |
| FDA Status | FDA-approved for obesity and T2D | Not approved; GRAS status for food use only in Australia |
| Mechanism | GLP-1 receptor agonist, appetite suppression, gastric slowing | hGH fragment stimulating lipolysis without IGF-1 increase |
| Weight Loss Efficacy | 15-17% in clinical trials | No significant difference from placebo in Phase III |
| Side Effects | GI side effects, potential thyroid concerns | Minimal reported side effects |
| Cost | Very high (branded pharmaceutical) | Low to moderate (research peptide) |
Peptide Overviews
Semaglutide
AFDA ApprovedSemaglutide is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Ozempic, Rybelsus) and chronic weight management (Wegovy). One of the most studied peptide drugs in recent history.
AOD-9604
CPreclinicalAOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) originally developed for obesity treatment. It has been explored as a lipolytic agent in research but has not received FDA approval or GRAS status for any use.
GLP-1 Support Essentials
Products that can support side-effect management, hydration, and protein intake.
LMNT Electrolyte Packets
Sodium-focused electrolytes to prevent dehydration and fatigue common in early GLP-1 therapy.
High-Protein Shakes (30g)
Convenient protein shakes to maintain muscle mass on reduced GLP-1 caloric intake.
Metamucil Fiber Supplement
Soluble fiber powder to manage constipation and GI side effects during GLP-1 treatment.
Vitamin B12 (Methylcobalamin 1000mcg)
GLP-1 agonists can reduce B12 absorption over time — methylcobalamin is the most bioavailable form.
Ginger Chews for Nausea
Natural nausea relief for the dose-escalation adjustment period, particularly weeks 1–4.
Unflavored Whey Protein Isolate
Preserve lean mass without excess carbs or calories when appetite is suppressed.
Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.
Supplies for Both
Common research handling and preparation supplies for injectable peptide workflows.
Alcohol Prep Pads (200 ct)
Sterile 70% isopropyl pads for injection site preparation — essential for subcutaneous protocols.
1mL Insulin Syringes (28G)
Thin-gauge 28G syringes for subcutaneous peptide administration with minimal discomfort.
Sharps Disposal Container (1 Qt)
Biohazard-safe sharps container for responsible disposal of used syringes.
Digital Milligram Scale (0.001g)
High-precision scale for accurate measurement of peptide powder before reconstitution.
Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.
Recommended Reading
Books covering peptide science, longevity research, and biohacking frameworks.
The Peptide Protocols
Comprehensive reference for peptide mechanisms, dosing research, and clinical applications.
Boundless by Ben Greenfield
Covers peptides, nootropics, hormones, and longevity strategies in an optimization framework.
Lifespan by David Sinclair
Evidence-based deep-dive into aging science, directly relevant to longevity peptide research.
The Longevity Paradox
Gut-centric aging research with diet and supplementation protocols for extending healthspan.
Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.
Semaglutide vs AOD-9604: FAQ
Join the France comparison waitlist
We will notify you when France-specific legal, pricing, provider, and tracker flows are available for comparison pages.
No spam. Unsubscribe anytime.
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.